| Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial A Widmark, O Klepp, A Solberg, JE Damber, A Angelsen, P Fransson, ... The Lancet 373 (9660), 301-308, 2009 | 970 | 2009 |
| Outcome in a prospective phase II trial of medically inoperable stage I non–small-cell lung cancer patients treated with stereotactic body radiotherapy P Baumann, J Nyman, M Hoyer, B Wennberg, G Gagliardi, I Lax, ... Journal of Clinical Oncology 27 (20), 3290-3296, 2009 | 968 | 2009 |
| Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial A Widmark, A Gunnlaugsson, L Beckman, C Thellenberg-Karlsson, ... The Lancet 394 (10196), 385-395, 2019 | 666 | 2019 |
| Phase II study on stereotactic body radiotherapy of colorectal metastases M Hoyer, H Roed, A Traberg Hansen, L Ohlhuis, J Petersen, H Nellemann, ... Acta oncologica 45 (7), 823-830, 2006 | 490 | 2006 |
| Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document Y Lievens, M Guckenberger, D Gomez, M Hoyer, P Iyengar, I Kindts, ... Radiotherapy and Oncology 148, 157-166, 2020 | 411 | 2020 |
| Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma M Hoyer, H Roed, L Sengelov, A Traberg, L Ohlhuis, J Pedersen, ... Radiotherapy and oncology 76 (1), 48-53, 2005 | 394 | 2005 |
| Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma TO Jensen, H Schmidt, HJ Moller, M Hoyer, MB Maniecki, P Sjoegren, ... J Clin oncol 27 (20), 3330-3337, 2009 | 328 | 2009 |
| Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma TO Jensen, H Schmidt, HJ Møller, F Donskov, M Høyer, P Sjoegren, ... Cancer 118 (9), 2476-2485, 2012 | 299 | 2012 |
| ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer M Guckenberger, N Andratschke, K Dieckmann, MS Hoogeman, M Hoyer, ... Radiotherapy and Oncology 124 (1), 11-17, 2017 | 284 | 2017 |
| Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries P Baumann, J Nyman, I Lax, S Friesland, M Hoyer, S Rehn Ericsson, ... Acta oncologica 45 (7), 787-795, 2006 | 274 | 2006 |
| Radiotherapy for liver metastases: a review of evidence M Høyer, A Swaminath, S Bydder, M Lock, AM Romero, B Kavanagh, ... International Journal of Radiation Oncology* Biology* Physics 82 (3), 1047-1057, 2012 | 214 | 2012 |
| Toxicity of concurrent stereotactic radiotherapy and targeted therapy or immunotherapy: a systematic review SGC Kroeze, C Fritz, M Hoyer, SS Lo, U Ricardi, A Sahgal, R Stahel, ... Cancer treatment reviews 53, 25-37, 2017 | 204 | 2017 |
| Stereotactic body radiotherapy for unresectable cholangiocarcinoma N Kopek, MI Holt, AT Hansen, M Høyer Radiotherapy and Oncology 94 (1), 47-52, 2010 | 204 | 2010 |
| The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis AC Begg, K Haustermans, AAM Hart, S Dische, M Saunders, B Zackrisson, ... Radiotherapy and Oncology 50 (1), 13-23, 1999 | 190 | 1999 |
| Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: dependency on tumor differentiation O Hansen, J Overgaard, HS Hansen, M Overgaard, M Høyer, ... Radiotherapy and oncology 43 (1), 47-51, 1997 | 190 | 1997 |
| The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas M Nordsmark, M Høyer, J Keller, OS Nielsen, OM Jensen, J Overgaard International Journal of Radiation Oncology* Biology* Physics 35 (4), 701-708, 1996 | 180 | 1996 |
| Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer M Thor, JBB Petersen, L Bentzen, M Høyer, LP Muren Acta Oncologica 50 (6), 918-925, 2011 | 149 | 2011 |
| Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer L Fokdal, H Honoré, M Høyer, P Meldgaard, K Fode, H von der Maase International Journal of Radiation Oncology* Biology* Physics 59 (2), 436-444, 2004 | 143 | 2004 |
| Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer–a first report of toxicity related to COPD/CVD in a non-randomized … P Baumann, J Nyman, M Hoyer, G Gagliardi, I Lax, B Wennberg, ... Radiotherapy and Oncology 88 (3), 359-367, 2008 | 141 | 2008 |
| Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus M Lambrecht, DBP Eekers, C Alapetite, NG Burnet, V Calugaru, ... Radiotherapy and Oncology 128 (1), 26-36, 2018 | 126 | 2018 |
Jorgen PetersenMedical PhysicistVerified email at rm.dk
